Dr. Thomas Scott Grogean, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1700 S Tamiami Trail, Sarasota, FL 34239 Phone: 941-917-2342 Fax: 941-917-4178 |
Dr. Amy Michelle Roth, DO Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1700 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-917-4896 Fax: 941-917-6884 |
Stephanie Vasko, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1700 S Tamiami Trl, Sarasota, FL 34239 Phone: 941-917-4896 Fax: 941-917-6884 |
News Archive
A preliminary study suggests that a new, wireless patch that you wear on your arm may help reduce migraine pain as well as drugs. The study is published in the March 1, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A new study suggests that exposure to dust from homes with dogs may alter the immune response to allergens and other asthma triggers by affecting the composition of the gut microbiome-the community of microbes that naturally colonize the digestive tract.
Researchers at the Osteoporosis and Metabolic Bone Disease Center and the Division of Gastroenterology at Loyola University Health System are studying a once-yearly, 15-minute infusion of an intravenous (IV) medication in patients with osteopenia (low bone mass) and inflammatory bowel diseases (IBD) that, if proven effective, may be considered the standard of treatment.
The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products.
› Verified 4 days ago